Kuehn Law Investigates Breach of Fiduciary Duties at Rocket Pharmaceuticals#USA#New_York#Kuehn_Law#Rocket_Pharmaceuticals#RCKT
Kuehn Law Investigates Breach of Fiduciary Duties at Rocket Pharmaceuticals
Kuehn Law is urging shareholders of Rocket Pharmaceuticals to come forward regarding potential breaches of fiduciary duties by company executives.
third-news.com
September 19, 2025 at 5:37 PM
Kuehn Law Investigates Breach of Fiduciary Duties at Rocket Pharmaceuticals#USA#New_York#Kuehn_Law#Rocket_Pharmaceuticals#RCKT
Class Action Lawsuit Filed Against Rocket Pharmaceuticals: Key Details for Investors#United_States#New_York#Pomerantz_LLP#Rocket_Pharmaceuticals#RCKT
Class Action Lawsuit Filed Against Rocket Pharmaceuticals: Key Details for Investors
Pomerantz Law Firm announces a class action lawsuit against Rocket Pharmaceuticals. Key deadlines are approaching for affected investors to take action.
third-news.com
August 11, 2025 at 2:55 PM
Class Action Lawsuit Filed Against Rocket Pharmaceuticals: Key Details for Investors#United_States#New_York#Pomerantz_LLP#Rocket_Pharmaceuticals#RCKT
Legal Action Initiated Against Rocket Pharmaceuticals Over Misleading Statements to Investors#USA#New_York#Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Legal Action Initiated Against Rocket Pharmaceuticals Over Misleading Statements to Investors
Rocket Pharmaceuticals faces a class action lawsuit for allegedly misleading investors about clinical trial risks. Affected shareholders encouraged to participate.
third-news.com
August 11, 2025 at 12:56 PM
Legal Action Initiated Against Rocket Pharmaceuticals Over Misleading Statements to Investors#USA#New_York#Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Investors of Rocket Pharmaceuticals Urged to Take Action on Securities Fraud Lawsuit#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Urged to Take Action on Securities Fraud Lawsuit
Rocket Pharmaceuticals, Inc. investors facing significant losses are reminded of an urgent opportunity to participate in a securities fraud lawsuit, with a deadline approaching.
third-news.com
August 10, 2025 at 9:15 PM
Investors of Rocket Pharmaceuticals Urged to Take Action on Securities Fraud Lawsuit#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Rocket_Pharmaceuticals
Investors Urged by Faruqi & Faruqi Regarding Rocket Pharmaceuticals Class Action Lawsuit Deadline#New_York#Faruqi_&_Faruqi#Rocket_Pharmaceuticals#RCKT
Investors Urged by Faruqi & Faruqi Regarding Rocket Pharmaceuticals Class Action Lawsuit Deadline
Faruqi & Faruqi informs investors of a critical class action lawsuit deadline against Rocket Pharmaceuticals, urging affected shareholders to act before August 11, 2025.
third-news.com
August 9, 2025 at 12:04 PM
Investors Urged by Faruqi & Faruqi Regarding Rocket Pharmaceuticals Class Action Lawsuit Deadline#New_York#Faruqi_&_Faruqi#Rocket_Pharmaceuticals#RCKT
Investors Encouraged to Reach Out Ahead of Deadline for Rocket Pharmaceuticals Lawsuit#United_States#Philadelphia#Securities_Class_Action#Berger_Montague#Rocket_Pharmaceuticals
Investors Encouraged to Reach Out Ahead of Deadline for Rocket Pharmaceuticals Lawsuit
Berger Montague notifies Rocket Pharmaceuticals investors of a looming deadline for a class action lawsuit. Learn your rights and eligibility for compensation.
third-news.com
August 8, 2025 at 6:29 PM
Investors Encouraged to Reach Out Ahead of Deadline for Rocket Pharmaceuticals Lawsuit#United_States#Philadelphia#Securities_Class_Action#Berger_Montague#Rocket_Pharmaceuticals
Join the Class Action Against Rocket Pharmaceuticals Before the Deadline#USA#New_York#Levi_&_Korsinsky#Rocket_Pharmaceuticals#RCKT
Join the Class Action Against Rocket Pharmaceuticals Before the Deadline
Levi & Korsinsky, LLP invites investors in Rocket Pharmaceuticals to join a class action lawsuit regarding securities fraud. The deadline is August 11, 2025.
third-news.com
August 8, 2025 at 12:52 PM
Join the Class Action Against Rocket Pharmaceuticals Before the Deadline#USA#New_York#Levi_&_Korsinsky#Rocket_Pharmaceuticals#RCKT
Join the Class Action Suit Against Rocket Pharmaceuticals to Seek Financial Recovery#United_States#New_York#Class_Action#Rocket_Pharmaceuticals#RCKT
Join the Class Action Suit Against Rocket Pharmaceuticals to Seek Financial Recovery
Attention Rocket Pharmaceuticals investors: The Gross Law Firm invites you to join the class action suit for recovery of losses suffered due to misleading statements and failures to disclose crucial information.
third-news.com
August 7, 2025 at 1:16 PM
Join the Class Action Suit Against Rocket Pharmaceuticals to Seek Financial Recovery#United_States#New_York#Class_Action#Rocket_Pharmaceuticals#RCKT
Class Action Alert: Rocket Pharmaceuticals Faces Investor Lawsuit Amid Serious Adverse Events#United_States#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Class Action Alert: Rocket Pharmaceuticals Faces Investor Lawsuit Amid Serious Adverse Events
Pomerantz Law Firm warns Rocket Pharmaceuticals investors of a class action lawsuit stemming from significant losses due to adverse trial events. Upcoming deadlines for lead plaintiff applications are crucial.
third-news.com
August 6, 2025 at 2:55 PM
Class Action Alert: Rocket Pharmaceuticals Faces Investor Lawsuit Amid Serious Adverse Events#United_States#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Legal Action Looms as Rocket Pharmaceuticals Faces Class Action Suit Over Recent Allegations#United_States#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Legal Action Looms as Rocket Pharmaceuticals Faces Class Action Suit Over Recent Allegations
Pomerantz Law Firm is reminding investors about a class action lawsuit against Rocket Pharmaceuticals. Investors with losses should act soon.
third-news.com
August 6, 2025 at 2:21 PM
Legal Action Looms as Rocket Pharmaceuticals Faces Class Action Suit Over Recent Allegations#United_States#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Berger Montague Notifies Rocket Pharmaceuticals Investors About Class Action Deadline on August 11, 2025#USA#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals#RCKT
Berger Montague Notifies Rocket Pharmaceuticals Investors About Class Action Deadline on August 11, 2025
Investors in Rocket Pharmaceuticals are urged to pursue a securities fraud lawsuit before the impending August 11, 2025 deadline, following serious allegations.
third-news.com
August 5, 2025 at 7:19 PM
Berger Montague Notifies Rocket Pharmaceuticals Investors About Class Action Deadline on August 11, 2025#USA#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Investors Urged to Act Before Deadline for Securities Fraud Lawsuit Compensation#United_States#New_York#Securities_Fraud#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Investors Urged to Act Before Deadline for Securities Fraud Lawsuit Compensation
Rocket Pharmaceuticals, Inc. investors have until August 11, 2025, to join a class action lawsuit regarding significant losses, potentially recovering compensation without upfront fees.
third-news.com
August 5, 2025 at 6:35 PM
Rocket Pharmaceuticals Investors Urged to Act Before Deadline for Securities Fraud Lawsuit Compensation#United_States#New_York#Securities_Fraud#Rocket_Pharmaceuticals#RCKT
Opportunity for Rocket Pharmaceuticals Investors to Lead Securities Fraud Lawsuit Against RCKT#USA#Los_Angeles#Securities_Fraud#Rocket_Pharmaceuticals#RCKT
Opportunity for Rocket Pharmaceuticals Investors to Lead Securities Fraud Lawsuit Against RCKT
Investors in Rocket Pharmaceuticals who suffered losses are now given the chance to lead a securities fraud class action lawsuit against the company. Take action now.
third-news.com
August 5, 2025 at 4:39 PM
Opportunity for Rocket Pharmaceuticals Investors to Lead Securities Fraud Lawsuit Against RCKT#USA#Los_Angeles#Securities_Fraud#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Faces Securities Lawsuit Over Alleged Fraudulent Misleading Statements to Investors#USA#New_York#Levi_&_Korsinsky#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Faces Securities Lawsuit Over Alleged Fraudulent Misleading Statements to Investors
Rocket Pharmaceuticals, Inc. is currently being sued for alleged securities law violations, impacting numerous investors. Important information here.
third-news.com
August 5, 2025 at 1:34 PM
Rocket Pharmaceuticals Faces Securities Lawsuit Over Alleged Fraudulent Misleading Statements to Investors#USA#New_York#Levi_&_Korsinsky#Rocket_Pharmaceuticals#RCKT
Investors of Rocket Pharmaceuticals Have Chance to Lead Class Action Lawsuit by Next Week#USA#Robbins_Geller#San_Diego#class_action_lawsuit#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Have Chance to Lead Class Action Lawsuit by Next Week
Investors who suffered significant losses from Rocket Pharmaceuticals can now lead a class action lawsuit in New Jersey. Affected individuals have until August 11, 2025, to act.
third-news.com
August 4, 2025 at 10:14 PM
Investors of Rocket Pharmaceuticals Have Chance to Lead Class Action Lawsuit by Next Week#USA#Robbins_Geller#San_Diego#class_action_lawsuit#Rocket_Pharmaceuticals
Rocket Pharmaceuticals Faces Lawsuit Over Alleged Securities Violations: Important Update for Investors#United_States#New_York#Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Faces Lawsuit Over Alleged Securities Violations: Important Update for Investors
Rocket Pharmaceuticals, Inc. is facing a lawsuit for alleged securities law violations. Investors are urged to connect with The Gross Law Firm for guidance and updates.
third-news.com
August 4, 2025 at 1:10 PM
Rocket Pharmaceuticals Faces Lawsuit Over Alleged Securities Violations: Important Update for Investors#United_States#New_York#Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Investors of Rocket Pharmaceuticals Can Take Lead Role in SEC Fraud Lawsuit Over Safety Claims#United_States#New_York#Faruqi_&_Faruqi#Rocket_Pharmaceuticals#RCKT
Investors of Rocket Pharmaceuticals Can Take Lead Role in SEC Fraud Lawsuit Over Safety Claims
Investors who suffered significant losses with Rocket Pharmaceuticals are encouraged to join a class action suit, spearheaded by Faruqi & Faruqi, LLP. Act before the deadline!
third-news.com
August 3, 2025 at 1:14 PM
Investors of Rocket Pharmaceuticals Can Take Lead Role in SEC Fraud Lawsuit Over Safety Claims#United_States#New_York#Faruqi_&_Faruqi#Rocket_Pharmaceuticals#RCKT
Investors of Rocket Pharmaceuticals Alerted to Class Action Lawsuit Amid Allegations of Securities Fraud#USA#New_York#Levi_Korsinsky#Rocket_Pharmaceuticals#RCKT_Class_Action
Investors of Rocket Pharmaceuticals Alerted to Class Action Lawsuit Amid Allegations of Securities Fraud
A new class action lawsuit has been filed against Rocket Pharmaceuticals. Investors affected by alleged securities fraud are urged to respond before the deadline.
third-news.com
August 1, 2025 at 1:22 PM
Investors of Rocket Pharmaceuticals Alerted to Class Action Lawsuit Amid Allegations of Securities Fraud#USA#New_York#Levi_Korsinsky#Rocket_Pharmaceuticals#RCKT_Class_Action
Deadline Approaches for Rocket Pharmaceuticals Class Action Lawsuit: What Investors Need to Know#United_States#Class_Action#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals
Deadline Approaches for Rocket Pharmaceuticals Class Action Lawsuit: What Investors Need to Know
Investors in Rocket Pharmaceuticals should act soon as the class action lawsuit deadline approaches. Learn more about potential claims and risks involved.
third-news.com
August 1, 2025 at 12:50 PM
Deadline Approaches for Rocket Pharmaceuticals Class Action Lawsuit: What Investors Need to Know#United_States#Class_Action#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Can Lead Fraud Lawsuit by August 2025#USA#New_York#Investor_Rights#Rosen_Law_Firm#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Can Lead Fraud Lawsuit by August 2025
Investors with losses exceeding $100K in Rocket Pharmaceuticals have the chance to lead a securities fraud lawsuit by the August 11, 2025 deadline.
third-news.com
July 31, 2025 at 10:22 PM
Investors of Rocket Pharmaceuticals Can Lead Fraud Lawsuit by August 2025#USA#New_York#Investor_Rights#Rosen_Law_Firm#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Have a Chance to Lead a Securities Fraud Lawsuit#United_States#Class_Action#Los_Angeles#Securities_Fraud#Rocket_Pharmaceuticals
Investors of Rocket Pharmaceuticals Have a Chance to Lead a Securities Fraud Lawsuit
Rocket Pharmaceuticals, Inc. investors who have suffered financial losses now have the opportunity to act as lead plaintiffs in a securities fraud lawsuit. Find out how to participate.
third-news.com
July 31, 2025 at 4:36 PM
Investors of Rocket Pharmaceuticals Have a Chance to Lead a Securities Fraud Lawsuit#United_States#Class_Action#Los_Angeles#Securities_Fraud#Rocket_Pharmaceuticals
Pomerantz Law Firm Warns Rocket Pharmaceuticals Investors of Class Action Lawsuit and Important Deadlines#USA#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Pomerantz Law Firm Warns Rocket Pharmaceuticals Investors of Class Action Lawsuit and Important Deadlines
Pomerantz LLP has announced a class action lawsuit against Rocket Pharmaceuticals, Inc., urging affected investors to take action before impending deadlines.
third-news.com
July 31, 2025 at 2:45 PM
Pomerantz Law Firm Warns Rocket Pharmaceuticals Investors of Class Action Lawsuit and Important Deadlines#USA#New_York#Class_Action#Pomerantz_Law#Rocket_Pharmaceuticals
Rocket Pharmaceuticals Investors Advised to Contact Legal Team About Rights Before August 2025 Deadline#United_States#New_York#The_Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Rocket Pharmaceuticals Investors Advised to Contact Legal Team About Rights Before August 2025 Deadline
Shareholders of Rocket Pharmaceuticals, Inc. are urged to reach out to The Gross Law Firm before August 11, 2025, to understand their legal rights related to recent company disclosures.
third-news.com
July 31, 2025 at 1:10 PM
Rocket Pharmaceuticals Investors Advised to Contact Legal Team About Rights Before August 2025 Deadline#United_States#New_York#The_Gross_Law_Firm#Rocket_Pharmaceuticals#RCKT
Investors in Rocket Pharmaceuticals May Lead Class Action Against Securities Fraud#USA#Class_Action#Securities_Fraud#Bensalem#Rocket_Pharmaceuticals
Investors in Rocket Pharmaceuticals May Lead Class Action Against Securities Fraud
Investors with significant losses in Rocket Pharmaceuticals, Inc. have an opportunity to lead a class action lawsuit for securities fraud. Don't miss your chance.
third-news.com
July 30, 2025 at 4:10 PM
Investors in Rocket Pharmaceuticals May Lead Class Action Against Securities Fraud#USA#Class_Action#Securities_Fraud#Bensalem#Rocket_Pharmaceuticals
Berger Montague Sends Urgent Deadline Reminder for Rocket Pharmaceuticals Class Action Investors#USA#Class_Action#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals
Berger Montague Sends Urgent Deadline Reminder for Rocket Pharmaceuticals Class Action Investors
Berger Montague urges investors in Rocket Pharmaceuticals to act before the August 11, 2025, deadline related to their class action lawsuit.
third-news.com
July 29, 2025 at 9:15 PM
Berger Montague Sends Urgent Deadline Reminder for Rocket Pharmaceuticals Class Action Investors#USA#Class_Action#Philadelphia#Berger_Montague#Rocket_Pharmaceuticals